| Old Articles: <Older 54661-54670 Newer> |
|---|
 |
The Motley Fool
January 4, 2012
Rich Smith |
2012 Preview: Alcatel-Lucent Which stocks should you buy in 2012?   |
The Motley Fool
January 4, 2012
Rebecca Lipman |
Biotech Ideas: Top Biotech Stocks with Bullish Institutional Trends "Smart money" investors are feeling bullish about these biotech companies: Amyris... VIVUS... InterMune... Savient Pharmaceuticals... Bacterin International... Seattle Generics... Oncothyreon... |
The Motley Fool
January 4, 2012
Rebecca Lipman |
Trading Strategy: 2012 Dogs of the Dow Are any of these names in your portfolio -- or on your watch list? |
The Motley Fool
January 4, 2012
Rebecca Lipman |
Commodity Stocks: List of Top Hedge Fund Favorites All of these names have seen significant institutional selling -- are these trends about to reverse? |
The Motley Fool
January 4, 2012
Rebecca Lipman |
Holiday Hangover: Retail Companies Face Prospect of Record Returns Insider executives are optimistic on the outlook of these companies -- do you agree? |
The Motley Fool
January 4, 2012
John Maxfield |
Can Barnes & Noble Survive Another Year? The question isn't if the struggling bookseller will perish, but when. |
The Motley Fool
January 4, 2012
Anders Bylund |
A Reverse Split Can't Fix This Broken Stock This once-proud stock is inevitably sliding toward the edge of oblivion. |
The Motley Fool
January 4, 2012
Rick Aristotle Munarriz |
5 Stocks That More Than Doubled in 2011 No one saw these five stocks coming, but they leave behind lessons worth learning. |
The Motley Fool
January 4, 2012
Rebecca Lipman |
Asian Stocks: Can Asian Economies Withstand Europe's Troubles? Do you think these names will see more bullish surprises in the future? |
The Motley Fool
January 4, 2012
Alyce Lomax |
Starbucks Plays With Pricing Starbucks is raising prices, but these hikes won't hit everybody where it hurts. They probably won't hurt the outlook for Starbucks shareholders, either. |
| <Older 54661-54670 Newer> Return to current articles. |
